Silicone oil has been used in the treatment of complex retinal detachments for many years.' However, many authors have reported postoperative anterior segment complications, such as cataract, glaucoma, and keratopathy even after successful reattachment of the retina.l The possibility of a toxic effect of silicone oil on the retina remains controversial" When silicone oil has been used in conjunction with vitrectomy, it can subsequently be easily removed via the pars plana in phakic eyes or via the limbus in aphakic eyes. It has been suggested that many complications may be prevented or their progression arrested when the silicone oil is removed a few weeks or months after surgery,' 13 but there are few reports detailing the effects of removing it either as a prophylactic measure or as part of the management of established complications.'I-16
The purpose of this study was to assess the effects of silicone oil removal on the anterior segment complications associated with its use. Peroperative and postoperative complications associated with silicone oil removal are reported in a separate communication. 7
Patients and methods
The hospital records of 92 consecutive patients who
Correspondence to Z J Gregor, FRCS. had undergone silicone oil removal were reviewed. All patients, under the care of five vitreoretinal surgeons at Moorfields Eye Hospital, presented with retinal detachments associated with giant retinal tears or proliferative vitreoretinopathy and were treated by vitrectomy and fluid/silicone oil exchange.
Patients with giant retinal tears and proliferative retinopathy were chosen because they represent the commonest indication for the use of silicone oil at this hospital. Patients underwent pars plana vitrectomy combined with epiretinal membrane dissection where appropriate and cryotherapy with scleral buckling as previously described.' 13 19 Many patients, particularly those with proliferative vitreoretinopathy, had undergone multiple surgical procedures before silicone oil injection. After silicone oil exchange, but prior to its removal, further procedures were carried out in 25 patients. Supplementary photocoagulation of the peripheral retina was undertaken in eight, additional cryotherapy in two, and cryotherapy with scleral buckling in six. Epiretinal membrane dissection and silicone oil 'top-up' was required in four. One patient required the insertion of an anterior chamber drainage tube for intractable glaucoma. Anterior chamber paracentesis was performed in four aphakic patients in whom oil completely filled the anterior chamber, giving rise to markedly raised intraocular pressure. The technique of silicone oil removal was that described by Leaver and Lean'9 ( Fig. 1) . In some patients oil removal was combined with other procedures including lensectomy, trabeculectomy, aqueous drainage tube, or penetrating keratoplasty. Additional cryotherapy, scleral buckling, and/or epiretinal membrane dissection was undertaken at the time of oil removal if there appeared to be peripheral retinal detachment or persistent epiretinal traction.
Fundi were examined by indirect ophthalmoscopy at the end of the procedure in order to establish that the retina remained attached and that no large silicone oil bubbles remained in the vitreous cavity. A subconjunctival injection of antibiotics and steroids was given in each case.
Those patients with secondary glaucoma underwent removal of silicone oil when the intraocular CATARACT The effect of removing silicone oil on the lens was studied in patients who were phakic at the time of oil removal and had at least six months' follow-up postoperatively. Twenty eight eyes were already aphakic when the oil was injected, and six underwent lens extraction at the time of oil removal. Of the 51 eyes which remained phakic after oil removal 16 developed retinal redetachment and were excluded. A further three patients were excluded with a followup of less than six months, leaving 32 for analysis (Table 1) . Eleven had clear lenses at the time of oil removal, and, of these, five remained clear at six months and six developed lens opacities. Twenty one already had lens opacities at the time of oil removal, and in 18 the lens opacities increased. This last group included five with lens opacities limited to early vesicular subcapsular opacities which cleared completely immediately after oil removal but recurred and progressed in each case after several weeks. Seven patients underwent cataract extraction during the period of follow-up. The relationship between the length of time that the oil was in situ and the development of lens opacities is shown in Table 1 . The mean length of time that the oil was in situ in eyes in which the lenses remained clear was 5-6 weeks, whereas in those which subsequently developed opacities it was 6-3 weeks. For patients whose pre-existing lens opacities did not progress the oil was in situ for a mean of 6-3 weeks, while for those who developed progressive changes the oil was in the eye for 10-6 weeks on average. No patient retained a clear lens if the oil remained in situ for more than 10 weeks.
Statistical analysis showed that eyes which developed lens opacities or in which lens opacities progressed had had silicone oil in situ for longer than those in which the lens status remained unchanged (p=0052). Logistic regression analysis showed that the length of time that the oil was in situ had a significant effect on the probability of developing increasing lens opacities and that, when that was taken into account, the lens clarity at the time of silicone oil removal had little effect on the chance of progression.
GLAUCOMA
Nineteen patients underwent removal of silicone oil as part of the treatment of otherwise uncontrollable glaucoma. Although the follow-up ranged from three months to 36 months (mean 15 months), only two patients had a follow-up of less than one year. Fifteen patients were aphakic and four were phakic. Of the four phakic patients a globule of oil was present in the anterior chamber in three. The mean duration of oil tamonade was 20 weeks. The intraocular pressure was raised from the time of silicone oil injection in eight patients, and the remaining 11 patients developed glaucoma between six and 20 months.
After oil removal without an additional drainage procedure the intraocular pressure was controlled by medical treatment alone in three patients and remained uncontrolled in two ( Table 2 ). One of the latter patients required a further injection of silicone oil after developing a retinal detachment. Of the nine patients who underwent trabeculectomy at or shortly Mean follow-up of 15 months.
after oil removal the intraocular pressure was controlled in four, was moderately raised in one (24 mmHg) , and in excess of 29 mmHg in four. Five patients were treated initially with the insertion of a silicone tube draining aqueous from the anterior chamber to a surrounding silicone explant. This was sufficient to control the intraocular pressure in two patients initially (one subsequently required cyclocryotherapy). In one patient the intraocular pressure remained moderately elevated (24 mmHg) and in two patients the intraocular pressure was uncontrolled (>30 mmHg).
Of the 66 patients without raised intraocular pressure at the time of oil removal (at 3-183 weeks with a mean of 15-0 weeks) five were found to have raised intraocular pressure following silicone oil removal. Of these patients one had congenital glaucoma, two developed raised pressure after a further injection of silicone oil for retinal redetachment and were controlled medically, and one developed mildly elevated intraocular pressure (24 mmHg) while the oil was in situ. Only one patient developed raised intraocular pressure following silicone oil removal; there was no other obvious predisposing cause and the intraocular pressure was controlled medically.
KERATOPATHY
Keratopathy was present in 11 eyes, nine aphakic and two phakic, and included five with glaucoma. The silicone oil was in situ for 16 to 240 weeks (mean 88 weeks) for patients with corneal problems alone and 16-60 weeks (mean 32 weeks) for patients with both glaucoma and keratopathy. A penetrating keratoplasty was required in two eyes at the time of silicone oil removal and in both patients the corneae remained clear at six months. In the nine remaining eyes there was an improvement of the corneal oedema in six. Four with coexistent glaucoma recovered a completely clear cornea and a gradual clearing of the central corneal oedema took place over several months in two. Corneal oedema was 24 " We therefore excluded analysis of those patients who developed retinal redetachment. Our results demonstrate that opacities continue to develop even after removal of the oil in many patients. The longer the oil remained in the eye, the greater the risk of progressive lens opacities subsequent to its removal. No patient in this series failed to develop opacities if the oil was present for longer than 10 weeks. Gonvers reported a high rate of cataract formation after oil removal (78%)'4 and our figures are in agreement with his.
We confirmed that glaucoma in patients following silicone oil injection occurs mostly in aphakic patients.z' Some patients developed glaucoma in the first weeks after oil injection. These patients were almost all aphakic and had a broad or superior peripheral iridectomy. Since early glaucoma in aphakes with silicone oil appears to be commonly due to pupil block, it may be altogether prevented by an inferior peripheral iridectomy.27 This has now become routine practice at this hospital but was not at the time that the patients in this series underwent surgery. Roussat None of the eyes with clear corneae at the time of oil removal developed corneal decompensation after the oil was removed. Most were phakic and the corneal endothelium was protected from direct contact with silicone oil. In aphakic eyes or in phakic patients with oil in the anterior chamber the oil was in situ for a relatively short time.
In the animal model silicone oil in the anterior chamber appears to cause loss of endothelial cells, resulting in corneal oedema.2'29 However, most of our patients whose anterior chambers were filled with silicone oil retained remarkably clear corneae. It has been suggested that a large silicone oil bubble in the anterior chamber prevents access of aqueous to the stroma,9 "' and thus corneal oedema does not develop even in the presence of a reduced endothelial cell count; rather, in this situation corneal thinning may develop. Corneal oedema may increase when the oil is removed and aqueous gains access to the corneal stroma. On the other hand the clearing of the mild central oedema in some of our patients after oil removal might be explained by the spreading out of the residual endothelial cells to replace the damaged cells.3 All three patients who had a penetrating keratoplasty with removal of silicone oil maintained a clear graft. It 
